glaxosmithkline

When one thinks of ghost writing, they may conjure up thoughts of secret writers and scheming in the background with some…

Today the New York Times published some of the findings of a report conducted by the Senate Finance Committee Staff on the…

If two recent cases highlighting plaintiff’s lawyer’s abuse of medical experts was not enough, last week the Sanders Firm…

The recent trend of media and Congress to call drug and pharmaceutical companies the “bad guys,” like Wall Street and AIG, only…

GlaxoSmithKline (NYSE: GSK) today announced new standards for funding accredited, continuing medical education (CME) for…